Cytokine & Growth Factor Reviews
Volume 21, Issue 2 , Pages 85-89 , April 2010

Navigating the clinical development landscape for oncolytic viruses and other cancer therapeutics: No shortcuts on the road to approval

  • Caroline J. Breitbach

      Affiliations

    • Jennerex Inc., San Francisco, CA, USA
    • ,
  • Tony Reid

      Affiliations

    • University of California, San Diego Cancer Center, La Jolla, CA, USA
    • ,
  • James Burke

      Affiliations

    • Billings Clinic, Billings, MT, USA
    • ,
  • John C. Bell

      Affiliations

    • Jennerex Inc., San Francisco, CA, USA
    • Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada
    • Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, ON, Canada
    • ,
  • David H. Kirn

      Affiliations

    • Jennerex Inc., San Francisco, CA, USA
    • Corresponding Author InformationCorresponding author at: Jennerex Inc. 201 Mission Suite 1380, San Francisco, CA 94105, USA.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1359-6101(10)00012-2

doi: 10.1016/j.cytogfr.2010.02.001

Cytokine & Growth Factor Reviews
Volume 21, Issue 2 , Pages 85-89 , April 2010

Article Tools

* Image Usage & Resolution